Work

No overall survival benefit to adding venetoclax for patients with RRMM

Year: 2025

Type: article

Abstract: APOLLO trial confirms ATRA-ATO use for patients with high-risk APL

Source: Cancer

DOI: 10.1002/cncr.70136

Author: Leah Lawrence

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4416935541

FWCI:

Cites: 3

Cited by:

Related to: